David Sidransky M.D.

Dr. Sidransky has served as a member of our Board of Directors since 2017. He is a renowned oncologist and research scientist named and profiled by TIME magazine in 2001 as one of the top physicians and scientists in America, recognized for his work with early detection of cancer. Since 1994, Dr. Sidransky is the Director of the Head and Neck Cancer Research Division and Professor of Oncology and Otolaryngology at Johns Hopkins University School of Medicine. Dr. Sidransky’s backgorund in life science companies, as well as his scientific knowledge and experience as a partner in IBF, qualify him to service as our director. He is currently the chairman of Ayala Pharma and Advaxis and is lead director at Champions Oncology and Galmed. He was a director and Vice-Chairman of ImClone Systems, Inc. until its merger with Eli Lilly and also serves on the Board of Directors of Orgenesis. He has served as Director (2005-2008) of the American Association for Cancer Research (AACR) and has received numerous scientific awards.